Viking Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Viking Therapeutics by Bank of New York Mellon
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $27M | 422k | 63.31 |
2024-06-30 | $22M | 407k | 53.01 |
2024-03-31 | $29M | 349k | 82.00 |
2023-12-31 | $6.3M | 338k | 18.61 |
2023-09-30 | $3.7M | 330k | 11.07 |
2023-06-30 | $5.5M | 338k | 16.21 |
2023-03-31 | $2.4M | 142k | 16.65 |
2022-12-31 | $1.5M | 158k | 9.40 |
2022-09-30 | $284k | 104k | 2.73 |
2022-06-30 | $305k | 106k | 2.88 |
2022-03-31 | $976k | 326k | 3.00 |
2021-12-31 | $1.1M | 258k | 4.35 |
2021-09-30 | $1.7M | 266k | 6.28 |
2021-06-30 | $1.5M | 250k | 5.99 |
2021-03-31 | $1.9M | 299k | 6.33 |
2020-12-31 | $1.7M | 300k | 5.63 |
2020-09-30 | $1.8M | 312k | 5.82 |
2020-06-30 | $2.3M | 315k | 7.21 |
2020-03-31 | $1.5M | 315k | 4.68 |
2019-12-31 | $2.5M | 311k | 8.02 |
2019-09-30 | $2.0M | 286k | 6.88 |
2019-06-30 | $3.1M | 369k | 8.30 |
2019-03-31 | $3.2M | 320k | 9.94 |
2018-12-31 | $3.0M | 387k | 7.65 |
2018-09-30 | $6.7M | 386k | 17.41 |
2018-06-30 | $3.3M | 346k | 9.48 |
2018-03-31 | $109k | 25k | 4.31 |